Lorenzo Brunetti

18PUBLICATIONS
94CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 08, 2026
Nuclear transcriptional condensates as drivers and therapeutic targets in NPM1-mutated AML.

Hannah Julia Uckelmann, Jayant Yadunath Gadrey, Lorenzo Brunetti

|Oct 17, 2024
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells.

Lorenzo Brunetti, Giulia Pianigiani, Michael C Gundry

|Dec 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AML.

Jad Othman, Manja Meggendorfer, Enrico Tiacci

|Dec 01, 2022
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.

Hannah J Uckelmann, Elena L Haarer, Reina Takeda

|Aug 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML.

Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma

Pageof 3